Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.
Smith GI, Shankaran M, Yoshino M, Schweitzer GG, Chondronikola M, Beals JW, Okunade AL, Patterson BW, Nyangau E, Field T, Sirlin CB, Talukdar S, Hellerstein MK, Klein S.
Smith GI, et al. Among authors: yoshino m.
J Clin Invest. 2020 Mar 2;130(3):1453-1460. doi: 10.1172/JCI134165.
J Clin Invest. 2020.
PMID: 31805015
Free PMC article.
Clinical Trial.